Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT

Bone Marrow Transplantation

Volumn 50, Issue 7, 2015, Pages 992-998

  Biagi, E ^a   Zama, D ^a   Nastasi, C ^a   Consolandi, C ^b   Fiori, J ^a   Rampelli, S ^a   Turroni, S ^a   Centanni, M ^a   Severgnini, M ^b   Peano, C ^b   De Bellis, G ^b   Basaglia, G ^a   Gotti, R ^a   Masetti, R ^a   Pession, A ^a   Brigidi, P ^a   Candela, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; INFLIXIMAB; PROPIONIC ACID; RNA 16S; SHORT CHAIN FATTY ACID; STEROID;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ARTICLE; BACTEROIDETES; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; DYSBIOSIS; ENGRAFTMENT; FATTY ACID SYNTHESIS; FECES ANALYSIS; FECES CULTURE; FEMALE; FEVER; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOMODULATION; INTESTINE FLORA; LONGITUDINAL STUDY; MALE; MASS FRAGMENTOGRAPHY; MICROBIAL POPULATION DYNAMICS; MICROBIOME; MUCOSAL IMMUNITY; NEUTROPENIA; NONHUMAN; OBSERVATIONAL STUDY; PHYLOGENY; POPULATION ABUNDANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PUVA; PYROSEQUENCING; SCHOOL CHILD; SYMBIONT; ACUTE DISEASE; ADVERSE EFFECTS; ALLOTRANSPLANTATION; COMPLICATION; GRAFT VERSUS HOST REACTION; PHYSIOLOGY;

ACUTE DISEASE; CHILD; FEMALE; GASTROINTESTINAL MICROBIOME; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LONGITUDINAL STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84934845521     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2015.16     Document Type: Article

References (42)

1. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature 2007; 449: 804-810.
2. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101: 15718-15723.
3. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007; 2: 204.
4. Lee YK, Mazmanian SK. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 2010; 330: 1768-1773.
5. Candela M, Turroni S, Biagi E, Carbonero F, Rampelli S, Fiorentini C et al. Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J Gastroenterol 2014; 20: 908-922.
6. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W et al. Host-gut microbiota metabolic interactions. Science 2012; 336: 1262-1267.
7. Segain JP, Raingeard de la Blétière D, Bourreille A, Leray V, Gervois N, Rosales C et al. Butyrate inhibits inflammatory responses through NF?B inhibition: implications for Crohn's disease. Gut 2000; 47: 397-403.
8. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013; 504: 451-455.
9. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011; 469: 543-547.
10. Petersson J, Schreiber O, Hansson GC, Gendler SJ, Velcich A, Lundberg JO et al. Importance and regulation of the colonic mucus barrier in a mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 2011; 300: G327-G333.
11. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464: 59-65.
12. Candela M, Biagi E, Turroni S, Maccaferri S, Figini P, Brigidi P. Dynamic efficiency of the human intestinal microbiota. Crit Rev Microbiol 2013; 9: 1-7.
13. Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL et al. The long term stability of the human gut microbiota. Science 2013; 341: 1237439.
14. Candela M, Biagi E, Maccaferri S, Turroni S, Brigidi P. Intestinal microbiota is a plastic factor responding to environmental changes. Trends Microbiol 2012; 20: 385-391.
15. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology 2009; 136: 65-80.
16. Tilg H, Moschen AR. Mechanisms behind the link between obesity and gastrointestinal cancers. Best Pract Res Clin Gastroenterol 2014; 28: 599-610.
17. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014; 20: 159-166.
18. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009; 373: 1550-1561.
19. Pasquini MC, Wang Z, Horowitz MM, Gale RP. 2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of haematopoietic cell transplants for blood and bone marrow disorders. Clin Transpl 2010, 87-105.
20. Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 2012; 12: 443-458.
21. van Bekkum DW, Roodenburg J, Heidt PJ, van der Waaij D. Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst 1974; 52: 401-404.
22. Jenq RR, Ubeda C, Taur Y, Menezes CC, Khanin R, Dudakov JA et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med 2012; 209: 903-911.
23. Holler E, Butzhammer P, Schmid K, Hundsrucker C, Koestler J, Peter K et al. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant 2014; 20: 640-645.
24. Heimesaat MM, Nogai A, Bereswill S, Plickert R, Fischer A, Loddenkemper C et al. MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease. Gut 2010; 59: 1079-1087.
25. Eriguchi Y, Takashima S, Oka H, Shimoji S, Nakamura K, Uryu H et al. Graft-versushost disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of ?-defensins. Blood 2012; 120: 223-231.
26. Tawara I, Liu C, Tamaki H, Toubai T, Sun Y, Evers R et al. Influence of donor microbiota on the severity of experimental graft-versus-host-disease. Biol Blood Marrow Transplant 2013; 19: 164-168.
27. Taur Y, Jenq RR, Perales MA, Littmann ER, Morjaria S, Ling L et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood 2014; 124: 1174-1182.
28. Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi MS, Martinelli G et al. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 2005; 353: 977-987.
29. Saral R, Burns WH, Laskin OL, Santos GW, Lietman PS. Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med 1981; 305: 63-67.
30. Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326: 845-851.
31. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
32. Salonen A, Nikkilä J, Jalanka-Tuovinen J, Immonen O, Rajili-Stojanovi M, Kekkonen RA et al. Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis. J Microbiol Methods 2010; 81: 127-134.
33. Centanni M, Turroni S, Consolandi C, Rampelli S, Peano C, Severgnini M et al. The enterocyte-associated intestinal microbiota of breast-fed infants and adults responds differently to a TNF-mediated pro-inflammatory stimulus. PLoS ONE 2013; 8: e81762.
34. Schnorr SL, Candela M, Rampelli S, Centanni M, Consolandi C, Basaglia G et al. Gut microbiome of the Hadza hunter-gatherers. Nat Commun 2014; 5: 3654.
35. Smith MI, Yatsunenko T, Manary MJ, Trehan I, Mkakosya R, Cheng J et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013; 339: 548-554.
36. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M et al. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-1638.
37. Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008; 6: e280.
38. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012; 489: 242-249.
39. Lee SM, Donaldson GP, Mikulski Z, Boyajian S, Ley K, Mazmanian SK. Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 2013; 501: 426-429.
40. Fishbach MA, Sonnenburg JL. Eating for two: how metabolism establishes interspecies interactions in the gut. Cell Host Microbe 2011; 10: 336-347.
41. Zwielehner J, Lassl C, Hippe B, Pointner A, Switzeny OJ, Remely M et al. Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting. PLoS ONE 2011; 6: e28654.
42. Dignan FL, Potter MN, Ethell ME, Taylor M, Lewis L, Brennan J et al. High readmission rates are associated with a significant economic burden and poor outcome in patients with grade III/IV acute GvHD. Clin Transplant 2013; 27: E56-E63.